Ongoing treatment(s)-Biological therapy-Monoclonal antibody Posts on Medivizor
Navigation Menu

Ongoing treatment(s)-Biological therapy-Monoclonal antibody Posts on Medivizor

A new treatment combination for patients with relapsed/refractory chronic lymphocytic leukemia

A new treatment combination for patients with relapsed/refractory chronic lymphocytic leukemia

Posted by on Apr 18, 2018 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the effectiveness of venetoclax (Venclexta) and rituximab (Rituxan) treatment in patients with relapsed/refractory chronic lymphocytic leukemia. This study concluded that venetoclax-rituximab treatment was effective for these patients.     Some background Chronic lymphocytic leukemia...

Read More